<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00948805</url>
  </required_header>
  <id_info>
    <org_study_id>0555/09</org_study_id>
    <nct_id>NCT00948805</nct_id>
  </id_info>
  <brief_title>Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment</brief_title>
  <official_title>Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was designed to evaluate the ability of gonadotropin releasing hormone (GnRh)
      agonist to prevent the rise of progesterone during controlled ovarian stimulation for in
      vitro fertilization (IVF) after the administration of human Chorionic Gonadotropin (hCG) on
      the first day of menses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to evaluate the efficacy of a GnRH agonist in preventing the
      functional rescue of corpus luteum in women submitted to controlled ovarian stimulation with
      administration of hCG on the first day of menses and to evaluate its effect on pregnancy rate
      and ovarian steroidogenesis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">July 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of functional rescue of corpus luteum</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of serum steroids</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of serum gonadotropins</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>GnRH agonist</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3,6 mg of goserelin acetate (GnRH agonist) will be administered on the 21st day of the menstrual cycle previous to ovarian stimulation. 250 mg of hCG will be administered on the first day of menses and a starting dose of 150 IU of FSH will be started 2 days later as a part of a long ovarian stimulation protocol. Ovulation will be triggered with a 250 mg of hCG when at least 2 follicles attain 18mm and to accommodate oocyte retrieval within 36 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>250 mg of hCG will be administered on the first day of menses and a starting dose of 150 IU of FSH will be started 2 days later as a part of a long ovarian stimulation protocol. Ovulation will be triggered with a 250 mg of hCG when at least 2 follicles attain 18mm and to accommodate oocyte retrieval within 36 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GnRH agonist</intervention_name>
    <description>3,6mg of goserelin acetate, 250mg of hCG, FSH variable dose according to the number of days required for appropriate ovarian stimulation</description>
    <arm_group_label>GnRH agonist</arm_group_label>
    <other_name>Ovidrel</other_name>
    <other_name>Zoladex</other_name>
    <other_name>Gonal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>250mg of hCG, Zoladex, FSH variable dose according to the number of days required for appropriate ovarian stimulation</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Zoladex</other_name>
    <other_name>Ovidrel</other_name>
    <other_name>Gonal</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;21 and &lt; 38 years old

          -  polycystic ovarian syndrome

          -  risk for ovarian hyperstimulation syndrome

        Exclusion Criteria:

          -  recurrent abortion

          -  endometriosis

          -  more than 3 IVF failures

          -  use of oral contraceptive pills in the preceding 3 months

          -  low response to gonadotropins
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paulo Serafini, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Gynecology of Faculty of Medicine of University of SãoPaulo (Disciplina de Ginecologia da Faculdade de Medicina da Universidade de São Paulo)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cláudia M Gomes, MD</last_name>
    <phone>551130596122</phone>
    <email>cgomes@huntington.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>André M Rocha, PhD</last_name>
    <phone>551130596122</phone>
    <email>arocha@huntington.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assisted Reproduction Center &quot;Governor Mário Covas&quot; of the Faculty of Medicine of the University of São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>05403000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cláudia Gomes, MD</last_name>
      <phone>551176569373</phone>
      <email>cgomes@huntington.com.br</email>
    </contact>
    <investigator>
      <last_name>Cláudia Gomes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.fm.usp.br</url>
    <description>University of São Paulo web page</description>
  </link>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2009</study_first_submitted>
  <study_first_submitted_qc>July 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2009</study_first_posted>
  <last_update_submitted>July 28, 2009</last_update_submitted>
  <last_update_submitted_qc>July 28, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Cláudia Messias Gomes</name_title>
    <organization>Gynecology of Faculty of Medicine of the University of SãoPaulo (Disciplina de Ginecologia da Faculdade de Medicina da Universidade de São Paulo)</organization>
  </responsible_party>
  <keyword>corpus luteum rescue</keyword>
  <keyword>Gonadotropin Releasing Hormone (GnRH agonist)</keyword>
  <keyword>human Chorionic Gonadotropin (hCG)</keyword>
  <keyword>infertility</keyword>
  <keyword>pregnancy rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Deslorelin</mesh_term>
    <mesh_term>Triptorelin Pamoate</mesh_term>
    <mesh_term>Luteolytic Agents</mesh_term>
    <mesh_term>Goserelin</mesh_term>
    <mesh_term>Chorionic Gonadotropin</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>August 4, 2011</submitted>
    <returned>September 7, 2011</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

